Research Scientist Job Description

A Research Scientist owns the scientific question. Research associates and technicians run protocols someone else wrote; the scientist writes them, decides which result would change the plan, and signs the interpretation. The title spans very different science. In a biotech target-discovery group it may mean building the case that a protein drives a disease, using CRISPR knockouts, organoids and RNA-seq. At a university institute it may mean running a grant-funded program in microbial ecology. At a national laboratory or a tech company it may mean developing new simulation or machine learning methods and proving they work on real data.

BLS's description of the closest federal occupation, medical scientists, is short: they "conduct research aimed at improving overall human health." The day-to-day work is more specific than that.

Designing the study. Before anything goes on a bench or a cluster, the scientist settles the hypothesis, the controls, the readout and the statistics. A well-designed study names in advance what result would kill the idea. Part of a senior scientist's job is spotting a confounded design before months of work go into it.

Running and troubleshooting. Scientists pipette, image, sequence and code as well as plan. When an assay drifts or a model overfits, the scientist decides whether the problem is the biology, the reagent, the instrument or the analysis.

Writing. Output is measured in papers, patents, internal reports and grant applications. Researchers funded by the National Institutes of Health now work under the 2024 NIH Public Access Policy, in effect since July 1, 2025, which requires accepted manuscripts to be submitted to PubMed Central upon acceptance for public availability without embargo on the official date of publication.

Rigor and records. Executive Order 14303, "Restoring Gold Standard Science," signed May 23, 2025, defines the standard federal agencies are to apply to their science: reproducible, transparent, communicative of error and uncertainty, structured for falsifiability of hypotheses and subject to unbiased peer review, among other tenets, and it directs each agency head, to the extent practicable, to incorporate that standard into agency scientific work. Industry scientists work under their own version of the same discipline: notebooks and raw data that survive due diligence, audits and patent disputes.

Patents. In companies, invention disclosures are part of the job. The scientist works with patent counsel to describe what is new, which experiments support each claim, and which named people conceived each element.

People and partners. Research Scientists mentor associates and postdocs, run collaborations with university partners and contract research organizations, and present to program leaders who decide funding. A good one tells those leaders plainly when the data say stop.

Education. Plan on a doctorate in the field you want to research: biology, biochemistry, chemistry, physics, materials science, statistics or computer science. In biomedical research, an M.D. or a combined M.D.-Ph.D. is another route for scientists who want to work close to patients. A strong master's degree plus several years as a research associate can also lead to scientist titles at some companies, given a visible record of independent work.

Postdoctoral training. As a rough guide, two to four years of postdoctoral work builds an independent publication record, and it is the stage where a researcher shifts from executing a mentor's project to running their own. Some drug and technology companies run their own postdoctoral programs.

Evidence of independence. A strong record shows ownership of the work:

• First-author papers in which the candidate designed the work, not just contributed data
• A technique, assay, dataset or software package that other groups adopted
• Invention disclosures or issued patents, for industry roles
• Fellowship or grant support won in the candidate's own name, such as an NIH F32 or K99/R00 award
• Talks at field conferences, which show the work holds up in front of peers

Technical depth. The expected toolkit depends on the field:

• Biology and drug discovery: CRISPR editing, flow cytometry, high-content imaging, single-cell and bulk sequencing, animal models, and the statistics to analyze them
• Chemistry and materials: synthesis, spectroscopy, chromatography, mass spectrometry, X-ray methods and electron microscopy
• Computational work: Python or R, version control, high-performance computing, and machine learning methods validated against held-out data
• Data practice in any field: electronic lab notebooks, written data management plans, and code and datasets deposited in public repositories so others can rerun the analysis

Compliance knowledge. Scientists who work with animals, human samples, recombinant DNA or hazardous chemicals complete institutional training and work under review committees such as an IACUC, IRB or institutional biosafety committee.

Certifications. None is typically required for the title. Some specialties have optional credentials, but a research scientist's credibility rests on the publication and invention record.

Communication. Expect a job talk and writing samples to test writing at the level of a peer-reviewed paper. Just as useful is the ability to explain a result and its uncertainty to a program manager who has to decide whether to fund the next phase.

Projected growth. BLS projects employment of medical scientists, the closest federal occupation for life-science research scientists, to grow 13 percent from 2025 to 2035, much faster than the average for all occupations. It expects about 10,500 openings for medical scientists each year, on average, over the decade, and BLS expects many of them to come from the need to replace workers who transfer to different occupations or exit the labor force. Chemists, physicists and computer research scientists have their own projections, so outlook for a physical-science or computing research scientist depends on the field.

Where the doctorates go. The National Science Foundation's report on 2024 doctorate recipients shows where new PhDs start. Of the 20,469 new doctorates with non-postdoc U.S. employment commitments in 2024, 40% were headed to academia, 40% to industry or business, 8% to government and 7% to nonprofits. Industry's share of these commitments more than doubled since 2004. Another 13,296 graduates reported a U.S. postdoc commitment.

Pay by setting. BLS industry data for May 2025 break the same occupation out by employer type. Medical scientists in scientific research and development services had a median of $125,740, those in pharmaceutical and medicine manufacturing $106,800, and those at colleges, universities and professional schools $80,210. BLS does not report research scientists separately, so these rows describe the medical scientist occupation as a whole.

Federal research policy. DOE has published an implementation plan for Executive Order 14303 on Gold Standard Science. The Department of Energy's 2026 annual update on its implementation, dated Sept. 2, 2026, says DOE will develop standardized metrics and evaluation mechanisms and provide training and resources to agency personnel to advance the order's tenets.

AI and shared research infrastructure. One federal AI-for-science effort is the Department of Energy's Genesis Mission. A Sept. 25, 2026 DOE Office of Science article describes it as mobilizing the national laboratories with industry, academia and other partners to build a unified scientific AI platform that connects supercomputing, AI, quantum systems and experimental facilities, aimed at 33 national science and technology challenges. On Oct. 15, 2026 DOE released Genesis Agent Skills, a set of technical resources for the mission, to help researchers and developers use what DOE calls Super Intelligence (SI) coding tools more effectively. The scientist's part is still validating what those tools produce before it reaches a paper or a patent.

Advancement. A company research organization can offer a scientific track through senior, principal and distinguished scientist titles or a management track through group leader and director roles. Moving up either one depends on a record of programs advanced or stopped on good evidence, people trained and work others build on.

Dear Dr. Okafor,

I am applying for the Research Scientist opening in your fibrosis biology group. I finished my Ph.D. in cell biology at Lakeshore University and am completing a postdoctoral fellowship at the Halvorsen Institute, where I study how lung fibroblasts switch into a scar-forming state after injury.

The core of my postdoc was a problem your team will recognize. Our primary fibroblast cultures drifted toward an activated state within days, which made every drug response hard to interpret. I built a three-dimensional culture system on soft hydrogels that kept cells quiescent for two weeks, validated it against single-cell sequencing from patient tissue, and then used it to run a pooled CRISPR screen. The screen pointed to a transcription co-factor that had not been linked to fibrosis before. I confirmed the hit with two independent guide sets and a small-molecule probe, and the paper describing the system and the screen is now in revision.

I designed that project, wrote the protocols, trained two technicians and a rotating graduate student to run it, and wrote the analysis pipeline in Python with version control so another lab could reproduce every figure. Two collaborating groups now use the culture system.

Your posting emphasizes target validation that holds up when a program moves toward the clinic. That is the part of research I care most about: knowing which result would make us stop, and saying so early. I would welcome the chance to discuss how my screening platform could support your target portfolio.

My CV and the revised manuscript are attached. Thank you for considering my application.

Sincerely, Maya Lindqvist